| |
| |
|
| Insider
Information: |
Glenn Gregory M |
| Relationship: |
President, R&D |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
18,339 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,593 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
18,339 |
|
|
| Total
Value |
$6,593 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President, R&D |
2023-03-10 |
18,339 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-08-18 |
4 |
S |
$143.94 |
$8,119,860 |
D/D |
(55,921) |
1,839 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-28 |
4 |
AS |
$107.22 |
$2,757,456 |
D/D |
(25,000) |
21,510 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-29 |
4 |
AS |
$106.17 |
$2,134,844 |
D/D |
(19,949) |
1,561 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-09-26 |
4 |
D |
$113.56 |
$2,116,645 |
D/D |
(18,639) |
21,510 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-08-18 |
4 |
OE |
$25.60 |
$1,876,525 |
D/D |
55,921 |
57,760 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-16 |
4 |
AS |
$272.42 |
$1,614,812 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-11-02 |
4 |
AS |
$177.12 |
$1,516,552 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-05 |
4 |
AS |
$170.80 |
$1,438,895 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-12-07 |
4 |
AS |
$150.30 |
$1,403,631 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-11-16 |
4 |
AS |
$166.89 |
$1,398,180 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-11-09 |
4 |
AS |
$164.23 |
$1,382,160 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-26 |
4 |
AS |
$130.93 |
$1,371,667 |
D/D |
(10,334) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-19 |
4 |
AS |
$161.00 |
$1,362,427 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-10-12 |
4 |
AS |
$161.58 |
$1,346,218 |
D/D |
(8,250) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
OE |
$5.95 |
$1,157,843 |
D/D |
10,531 |
7,630 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
AS |
$196.77 |
$1,144,387 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-03-15 |
4 |
AS |
$196.88 |
$1,134,400 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-06-15 |
4 |
AS |
$183.53 |
$1,094,130 |
D/D |
(5,716) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-04-15 |
4 |
OE |
$5.95 |
$1,083,775 |
D/D |
10,531 |
7,630 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-07-15 |
4 |
AS |
$177.62 |
$1,014,597 |
D/D |
(5,654) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-06-18 |
4 |
S |
$59.53 |
$997,103 |
D/D |
(16,749) |
1,839 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-08-26 |
4 |
AS |
$227.74 |
$974,740 |
D/D |
(4,167) |
4,061 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-05-17 |
4 |
AS |
$131.50 |
$765,267 |
D/D |
(5,712) |
2,811 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2020-06-18 |
4 |
OE |
$42.20 |
$706,808 |
D/D |
16,749 |
18,588 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2021-02-18 |
4 |
AS |
$264.09 |
$656,134 |
D/D |
(2,434) |
2,811 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
